Bridgeway Capital Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
VPM
VCM
CB
Bridgeway Capital Management's CNMD Position: Q1 2026 in Review
Bridgeway Capital Management reduced its CONMED (CNMD) stake by 3.1% in Q1 2026, selling an estimated $52.9K and leaving 41,000 shares worth $1.45M. The position accounts for 0.03% of the portfolio, ranked #619.
Bridgeway Capital Management first reported a position in CNMD in Q1 2020 and has held it in 7 quarters since. The position peaked at $2.18M in Q3 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Bridgeway Capital Management held 41,000 shares of CONMED worth $1.45M as of Q1 2026.
- Bridgeway Capital Management sold 1,300 CONMED shares in Q1 2026, an estimated $52.9K.
- CONMED made up 0.03% of Bridgeway Capital Management's portfolio in Q1 2026, its #619 holding.
- Bridgeway Capital Management first reported a position in CONMED in Q1 2020 and has held it in 7 quarters since.
- Bridgeway Capital Management's CONMED position peaked at $2.18M in Q3 2025.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.